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A B S T R A C T
Purpose: Knowledge about long-term colorectal cancer (CRC) or treatment related health and functioning pro-
blems and on its impact on participation of CRC survivors in domestic life and in society is limited. We aimed to
explore the nature and impact of cancer (treatment) related participation restrictions on everyday life of long-
term CRC survivors, their current satisfaction with participation, and associations of health and functioning
problems with participation satisfaction, using the International Classification of Functioning, Disability and
Health (ICF) to comprehensively study participation.
Method: Mixed-method study in 2–10 years post-diagnosis stage I-III CRC survivors (n = 151) from the cross-
sectional part of the EnCoRe study. Participation restrictions were explored by semi-structured interviews in a
subsample reporting participation restrictions (n = 10). Role functioning (SF36-Health Survey), fatigue
(Checklist Individual Strength), and peripheral neuropathy symptoms (EORTC QLQ-CIPN20) were assessed in all
participants and associations with self-reported participation satisfaction were analyzed by multivariable logistic
regression models.
Results: 19% of CRC survivors reported dissatisfaction with participation. Participation restrictions were re-
ported for interpersonal relationships, work/employment, and social/civic life. CRC survivors reporting better
physical and emotional role functioning were significantly less likely to be dissatisfied with their participation,
whereas survivors reporting higher levels of fatigue or more peripheral neuropathy symptoms were more likely
to be dissatisfied with participation.
Conclusions: Colorectal cancer (treatment) related health and functioning problems negatively impacts the
ability of nearly 1 in 5 long-term CRC survivors to participate in everyday life situations and their satisfaction
with participation. Follow-up care needs to be able to identify and address these problems.
1. Introduction
Following diagnosis and treatment, colorectal cancer (CRC) survi-
vors often experience persisting health and functioning problems due to
the cancer and its treatment, such as gastrointestinal problems, cancer-
related fatigue, symptoms of chemotherapy-induced peripheral neuro-
pathy (CIPN), and reduced physical and emotional functioning
(Altschuler et al., 2009; Averyt and Nishimoto, 2014; Bols et al., 2015;
Caravati-Jouvenceaux et al., 2011; Denlinger and Barsevick, 2009;
Desnoo and Faithfull, 2006; Domati et al., 2011; Drury et al., 2017;
Grant et al., 2011; Harrington et al., 2010; Jansen et al., 2010;
LeMasters et al., 2014; McCaughan et al., 2012; McMullen et al., 2008;
Mols et al., 2014a,b; Nikoletti et al., 2008; Ramirez et al., 2009;
Sweeney et al., 2006). These problems can severely limit the ability of
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CRC survivors to perform daily activities such as self-care, and may
restrict their level of participation in life situations. This refers to their
ability to participate in domestic life (such as performing household
tasks), to function as a member of society (e.g. the capacity to work),
and to participate in interpersonal interactions and relationships, and in
community and social events (World Health Organization, 2001).
However, until now it remains mostly unknown how health and func-
tioning problems influence participation of long-term CRC survivors.
Moreover, it is of importance to know what health and functioning
problems mean to CRC survivors, whether or not CRC survivors are
satisfied with their current participation, as well as factors related to
their level of satisfaction, to inform development of strategies to ad-
dress participation problems of CRC survivors.
Research on CRC survivors' satisfaction with participation is limited.
Those studies are usually performed in mixed populations of cancer
survivors, focus on specific aspects of participation (and implicitly sa-
tisfaction with participation), for example on social (Wright et al.,
2005) or work-related difficulties only (McGrath et al., 2017;
Rasmussen and Elverdam, 2008), or use specific theoretical models. A
study of Devins in six common cancers, including gastrointestinal
cancer, using the illness intrusiveness model, concludes that the psy-
chosocial impact of a chronic life-threatening disease plays a role
especially instrumental life domains, like work, finances, and health,
and depends on the context in which it is experienced (Devins et al.,
2006). A prospective study in CRC survivors observed that low opti-
mism, poorer social support, a more negative cognitive appraisal and
younger age were associated with poorer life satisfaction (defined as the
participants' subjective cognitive well-being) and health-related quality
of life, specifically in a later stage of disease and in females (Dunn et al.,
2013). A review of Catt et al. on the impact of cancer on patients’ lives
in a population with different cancer types, found high levels of fi-
nancial distress and social difficulties following cancer, but also the
need for studies investigating patient-reported outcomes focusing on
roles and responsibilities (e.g. related to work) (Catt et al., 2017).
For the ongoing cohort study in CRC survivors, the International
Classification of Functioning, Disability and Health (ICF) of the World
Health Organizanion (WHO) has been applied as a theoretical frame-
work, to systematically and comprehensively study lifestyle and health-
related quality of life in CRC survivors. Factors relevant to study life-
style and health related quality of life factors in CRC survivors were
identified from the literature and mapped within the ICF framework, to
develop an ICF-based conceptual model. Next, study measures were
selected based on this conceptual model, and the items of these mea-
sures were linked to the ICF model. This was done to determine whe-
ther the items that are part of the (sub)domains of the ICF, including
social participation, were sufficiently covered by the chosen measure-
ments (van Roekel et al., 2014). For this study, we used measures that
were linked to the domains of body functions and structures, activities
and participation of the ICF. The ICF is a useful holistic framework for
cancer survivorship research, and is allowing us to comprehensively
study participation restrictions and satisfaction with participation in
relation to CRC and its treatment. In this bio-psychosocial framework,
an individual's level of functioning is described using different domains
(body functions and structures, activities, and participation). These
domains are regarded as essential components of health. Importantly,
the ICF framework focuses not only on physical aspects of health and
functioning, but also on more qualitative features such as psychological
and social functioning, put in the context of relevant environmental and
personal factors that influence an individual's health and functioning
(Stephenson and Richardson, 2008) (Kostanjsek, 2011). Furthermore,
the ICF framework can be applied both in research practice and in
clinical practice, facilitating translation of findings to future survivor-
ship care.
The present study aimed to investigate participation, as defined in
the ICF framework comprising domestic life, social participation, labor
participation, community participation and recreation and leisure, in
long-term (2–10 years post-diagnosis) CRC survivors using a mixed-
methods approach. To explore how persistent problems in CRC survi-
vors potentially affect satisfaction with participation, we investigated
quantitative associations of physical and emotional role functioning,
fatigue, and CIPN with CRC survivors’ satisfaction with participation.
Next, to get additional insight and to illustrate findings, we qualita-
tively explored the impact of health and functioning problems resulting
from the cancer and its treatment on the current participation of CRC
survivors.
2. Methods
2.1. Study design and participants
Data was used from the cross-sectional part of the Energy for Life
after Colorectal cancer (EnCoRe) study, in long term stage I to III CRC
survivors, 2–10 years post diagnosis, which was initiated in 2012 at
Maastricht University in the Netherlands. Methods of our study have
been described in detail elsewhere (van Roekel et al., 2014). The ICF
framework is used as the theoretical basis in the EnCoRe-study to sys-
tematically and comprehensively study lifestyle and health-related
quality of life in CRC survivors (See Fig. 1).
In brief, eligible subjects were individuals diagnosed with and
treated for CRC (stage I-III), between 2002 and 2010 at Maastricht
University Medical Center+ (MUMC+), the Netherlands, 2–10 years
earlier. These individuals were preselected via the Netherlands Cancer
Registry (NCR; managed by Comprehensive Cancer Centre the
Netherlands) and approached by their Medial Doctor first by mail and
then by telephone by a study team member for participation. A home
visit was planned in case of willingness to participate, during which
written informed consent was obtained before the start of the study
measurements that were performed at participants’ homes. Data on
lifestyle behavior and related factors (diet, physical activity, and body
composition) and patient reported outcomes such as health related
quality of life were assessed by validated questionnaires. The EnCoRe
study had been approved by the Medical Ethics Committee of the
University Hospital Maastricht and Maastricht University, the
Netherlands. Data collection was performed in 2012 and 2013.
An additional qualitative study was carried out in 2014 and 2015
using subjects from the study population of the cross-sectional EnCoRe
study. Eligible subjects for the qualitative study were participants of the
cross-sectional study, who previously reported participation restric-
tions. Potential interview candidates were first approached by tele-
phone, after which an information letter for the qualitative study was
sent. After one week, potential interview candidates were contacted
again by phone to ask whether they had received, and understood the
information. After that, a comprehensive explanation of the study
content, consent needed for participation and for audiotaping the in-
terview, and information about confidentiality was given. In case in-
terview candidates were willing to participate in this interview, an
appointment for the interview was made. Additional written informed
consent was obtained for this part of the study from all participants,
after detailed information before the start of the interview at the pa-
tients’ home. Additional approval for the qualitative part of the study
was obtained from the Medical Ethics Committee of the University
Hospital Maastricht and Maastricht University, the Netherlands.
For the present study a sequential explanatory mixed-method design
was applied, to investigate participation in long-term CRC survivors.
Participation is defined as the ability to participate in domestic life
(such as performing household tasks), to function as a member of so-
ciety (e.g. the capacity to work), and to participate in interpersonal
interactions and relationships, and in community and social events
(World Health Organization, 2001). We additionally investigated what
health and functioning problems mean to CRC survivors. For this we
make use of quantitative data as the basis and additional qualitative
data to further explore, and get in-depth insight and understanding.
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Results of the qualitative study were connected to quantitative results
as additional information for a better understanding of the impact of
participation restrictions on health and functioning problems experi-
enced by the group CRC survivors.
Quantitative methods were used to assess CRC survivors’ satisfac-
tion with participation, and to analyze associations of physical and
emotional role functioning, fatigue and CIPN with participation sa-
tisfaction. For the quantitative part, data from all participants of the
cross-sectional EnCoRe study was used, which had been collected be-
tween May 2012 and December 2013.
The additional qualitative study was carried out using a descriptive
approach, to explore the nature and impact of persisting health and
functioning problems related to the prior cancer diagnosis and treat-
ment on current participation of CRC survivors. Individual semi-struc-
tured face-to-face interviews were performed in a purposive sample of
CRC survivors who had participated in the EnCoRe study, who pre-
viously reported participation restrictions, and who previously gave
permission to be approached again for additional research. Interviews
were held between October 2014 and March 2015.
2.2. Data collection, quantitative part
Satisfaction with participation was assessed by asking participants
to report whether their current satisfaction with participation in paid
jobs (yes/no), non-paid jobs (yes/no), household tasks (yes/no), and
hobbies (yes/no) was the same as compared to before their CRC diag-
nosis, reflecting the involvement in major life situations as defined by
the ICF. A negative answer to at least one of the questions was con-
sidered to reflect dissatisfaction with participation.
2.2.1. Role functioning, fatigue and chemotherapy-induced peripheral
neuropathy
The level of physical and emotional role functioning (i.e. physical or
emotional problems that limit work performance or other daily activ-
ities) was measured by the SF-36 Health Survey questionnaire
(VanDerzee and Sanderman,). The SF-36 has been validated in,
amongst others, cancer patients, and showed consistent support for the
validity of the SF-36. The SF-36 has a high internal consistency, with a
mean alpha coefficient across all scales and samples of 0.84(Aaronson
et al., 1998). The SF-36 has frequently been used in cancer survivors
(Fitzsimmons et al., 2009), and is comprised of subscales for assessing
problems in physical role functioning (based on 4 items) and in emo-
tional role functioning (based on 3 items). Item responses per subscale
were summed and transformed into a continuous scale ranging from 0
to 100 points, with a higher score indicating less problems (i.e. better
physical or emotional role functioning).
Fatigue was assessed by the Checklist Individual Strength (CIS),
which was originally developed and validated for patients with chronic
fatigue syndrome (Vercoulen et al., 1994, 1996), but has also been
applied in cancer survivors (Servaes et al., 2001). The CIS had a high
internal consistency in the current population for both the total score
(Cronbach's α = 0.93) and the subscales (Cronbach's α = 0.72). The
CIS consists of 20 items with 7-point Likert scale response options,
which were summed to create a continuous score ranging from 20 to
140 points, with higher scores indicating higher levels of fatigue
(Servaes et al., 2001; Vercoulen et al., 1994, 1996).
The 20-item cancer-specific European Organization for the Research
and Treatment of Cancer Chemotherapy-Induced Peripheral
Neuropathy 20 (EORTC QLQ-CIPN20) questionnaire was used to mea-
sure the severity of CIPN symptoms by means of sensory (9 items),
motor (8 items) and autonomic (3 items) symptom subscales. Each item
is scored on a scale ranging from 1 (not at all) to 4 (very much)
symptoms. Item responses were transformed into continuous subscale
scores ranging from 0 to 100 points, with higher scores indicating more
severe CIPN symptoms. CIPN20 questionnaire has been evaluated for its
psychometric properties in multiple studies, showing satisfactory va-
lidity, reliability, sensitivity, and responsiveness (Smith et al., 2019,
Smith et al., 2018).
2.2.2. Socio-demographic, lifestyle, and clinical characteristics
From our previously developed ICF-based conceptual model (van
Roekel et al., 2014), other relevant factors for studying participation of
CRC survivors were identified and measured, including socio-demo-
graphic, lifestyle, and clinical characteristics. Gender, age, living si-
tuation (alone yes/no), dietary changes since diagnosis (yes/no), and
current smoking status (yes/no) were collected through self-report.
Adherence to the Dutch physical activity guidelines (> 30 min of
moderate-to-vigorous physical activity on at least 5 days per week) was
Fig. 1. The International Classification of Functioning, Disability and Health Conceptual model.
The ICF conceptual model consists of two parts, a functioning part (comprising the domains ‘body functions and structures’, ‘activities’, and ‘participation’) and the
contextual factors (comprising environmental and personal factors).
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assessed by the Short QUestionnaire to ASsess Health-enhancing phy-
sical activity (SQUASH) (Wendel-Vos et al., 2003). Body height and
weight were measured by trained personnel for calculation of body
mass index (BMI, kg/m2). The presence of comorbidities was assessed
using the Self-Administered Comorbidity Questionnaire (Sangha et al.,
2003), and the presence of a stoma was assessed by self-report. Addi-
tional clinical data on cancer stage, tumour localization, and treatment
characteristics were collected through the Netherlands Cancer Registry.
2.3. Data collection, qualitative part
For the qualitative interviews, a total of 48 out of 151 participants
of the cross-sectional EnCoRe study were eligible, since they had pre-
viously reported participation restrictions by giving an affirmative an-
swer to one of the four items of the role limitations (due to physical
health) scale of the Short Form Health Survey (SF-36) questionnaire,
i.e., ‘Did you have any trouble with your work or other activities in the
past four weeks due to your physical health’ (Aaronson et al., 1998;
Ware and Sherbourne, 1992). To select interview candidates, we ap-
plied the non-probability purposive sampling technique of maximum
variation sampling (Etikan, 2016), based on representation of specific
characteristics across a broad spectrum for which we wanted to have
enough variance. The purposive sample characteristics to be re-
presented in our interview population were age (< 65 vs. ≥ 65 years),
gender (male vs. female), tumour stage (I, II and III), presence of co-
morbidities (0, 1, and ≥2 comorbidities), job (paid, unpaid or no job),
partner (yes/no), time since diagnosis (< 5 vs.> 5 years), and stoma
(yes/no). Interview candidates were selected from the eligible CRC
survivors based on the presence of these specific characteristics. Se-
lected interview candidates were contacted by telephone to ask per-
mission for sending a study information letter, and were contacted
again after one week to ask whether they agreed to participate in an
interview. Characteristics of already included interview participants
were kept up to date, and new interview candidates were selected based
on the specific characteristics that were still absent or underrepresented
in the group of previously interviewed participants, in order to achieve
maximum variation of sample characteristics. In that way, a balanced
interview population was obtained in which the different character-
istics were more or less equally represented. The selection of new in-
terview candidates was continued until data saturation was achieved,
which was considered to be the case when two consecutive interviews
did not reveal any new data relevant to the research question. Two pilot
interviews were executed, and evaluated afterwards. As no adjustments
were made in the final design, content and execution of the interview,
the data from the pilot interviews were included in the analyses.
The semi-structured interviews in Dutch were conducted using a
constructed guide with interview themes, which were based on the
topics of the participation domain of our previously constructed con-
ceptual ICF framework (van Roekel et al., 2014) (comprising domestic
life, social participation, labor participation, community participation
and recreation and leisure), and which were tailored to the present
research questions (Supplementary Table 1). Interview themes were
focused on the nature of restrictions in participation, such as partici-
pation in household tasks, labor participation and participation in so-
cial activities and hobbies, experienced by the CRC survivors as a result
of their prior cancer and treatment, as well as on the impact of these
restrictions on everyday life. Participants were interviewed in their own
homes by a trained interviewer, accompanied by an observer who took
notes. All interviews were digitally recorded, to enable data transcrip-
tion and to guarantee transparency. Preceding the interviews, consent
was obtained for conducting and audiotaping the interviews from all
interview participants.
To ensure rigour, and to make the study transparent and explicit,
the study was executed according to standardized procedures for all
parts of the study. For example standardized procedures were followed
for purposively sampling, for communication with potential interview
candidates, for data collection, and for performing data analysis. Logs
of activities were kept. All researchers involved were thoroughly
trained by experienced researchers, for the different study tasks, in-
cluding interviewing study participants and performing data analysis.
Every single interview was analyzed by two researchers, who in-
dependently identified relevant text fragments, summarized texts and
attached descriptive codes, mapped codes in the ICF categories. Results
of activities were compared systematically and differences were dis-
cussed until agreement was reached Checks on appropriate coding were
performed by another team member. Lastly, in regular meetings, study
execution and findings were discussed within the research team.
2.4. Data analyses
2.4.1. Quantitative data analyses
Data on satisfaction with participation and socio-demographic,
lifestyle and clinical characteristics were described as means and
standard deviations (SD) or as absolute (N) and relative (%) fre-
quencies. Socio-demographic, lifestyle and clinical characteristics were
also described in subgroups of participants who were satisfied with
their participation or not satisfied.
Multivariable logistic regression analyses were performed to assess
the association of physical and emotional role functioning, fatigue, and
CIPN as main independent variables with participation satisfaction
(yes/no) as binary dependent variable, to obtain odds ratios (OR) re-
flecting the likelihood of participation satisfaction for clinically re-
levant increments in the scores of physical or emotional functioning,
fatigue or CIPN. Clinically relevant increments were defined as 0.5
times the SD of the scores of main independent variables (Revicki et al.,
2008).
Multivariable logistic regression models were adjusted for relevant
confounders. Potential confounders were identified from literature and
entered in the model in a forward stepwise fashion to evaluate the
magnitude of potential confounding. When the change in estimate of
the beta was less than 10%, the potential confounding variable was
considered not relevant, and excluded from the model. This was the
case for Body Mass Index (BMI), stoma, smoking status, living situation,
tumor site, tumor stage, and self-reported dietary changes. The final
models were adjusted for age (years), gender, number of comorbidities
(0/1/≥2), and chemotherapy treatment (yes/no). Depending on the
main independent variable of interest, models were adjusted further for
the other independent variables to determine independent associations
(e.g. the association of physical role functioning was adjusted for
emotional role functioning and fatigue), except for models with the
CIPN symptom subscales as main independent variables because of high
correlations between CIPN subscales.
The assumptions for the use of multivariable logistic regression
models were tested. The linearity assumption was not violated (Field,
2013), and none of the models showed evidence for multicollinearity
(variation inflation factors ≤5) (Stine, 1995).
IBM SPSS Statistics version 21 was used and two-sided P-values<
0.05 were considered statistically significant.
2.4.2. Qualitative data analyses
A quantitative content analysis was performed on the qualitative
data from the semi-structured interviews (Forman and Damschroder,
2008). The recorded interview texts were transcribed verbatim, and
notes made by the observer were inserted as comments in the tran-
script. Text fragments relevant to answer the research question were
summarized, and descriptive codes were then assigned to the sum-
marized fragments. Each interview was coded by two researchers. Re-
sults of coding were compared and any differences were discussed until
consensus was reached. Next, the findings from each individual inter-
view were mapped into the applicable parts of the ICF framework and
linked to appropriate ICF categories within the domains ‘health con-
dition’, ‘body structure & functions, ‘activities’, ‘participation’,
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‘environmental factors’ and ‘personal factors’, based on published
linking rules. The ICF provides a standard language and framework for
the description of functioning and disability and health-related and
contextual factors. The ICF consists of an extensive list of items and
codes per domain and subdomain of functioning, representing a specific
aspect of functioning with a standardized definition or description.
Linking rules have been developed to facilitate the identification of
meaningful concepts in data and to link identified concepts to an ICF
code with a description (van Roekel et al., 2014). In this way, separate
overviews of ICF categories were created of the main biopsychosocial
areas reflecting health and functioning problems related to the CRC
diagnosis and treatment influencing participation that were mentioned
by each interview participant. As specific classifications for ‘personal
factors’ are not defined yet, we applied own terms, for example ‘coping’.
An overall summary of interview results was obtained by putting the
retrieved ICF categories of all separate overviews together in a single
ICF framework. The linking of interview findings to the ICF framework
was performed by two researchers. Results of linking to the ICF do-




Between 2002 and 2010, 772 individuals were diagnosed and
treated for CRC at Maastricht University Medical Center+ the
Netherlands. From this group 52% was not eligible, due to several
reasons (e.g. not alive, co-morbidities that obstruct successful partici-
pation such as Alzheimer disease). Eligible individuals (N = 373) were
invited to participate in the study, and from this group a total of 155
CRC survivors (42%) participated in the EnCoRe study, of whom 151
were included in the quantitative data analyses (Fig. 3). As shown in
Supplementary Table 2, compared to non-participants, included parti-
cipants were 3.9 years younger (P < 0.001), but did not significantly
differ otherwise.
CRC survivors (62.3% men, Table 1) had a mean age of 69.8 years
(SD = 8.7) and were on average 5.7 years since CRC diagnosis
(SD = 1.8). Nineteen percent of CRC survivors reported to be dis-
satisfied with their current level of participation. As shown in Table 2,
CRC survivors who were dissatisfied with participation had lower
physical role functioning and emotional role functioning scores than
survivors who reported to be satisfied with participation (33.7 and 61.7
vs. 81.8 and 93.1, respectively). CRC survivors reporting dissatisfaction
with participation had higher scores for fatigue than survivors who
reported to be satisfied with participation (77.3 vs. 52.1, respectively).
Within the subgroup of CRC survivors who had received chemotherapy,
more CIPN-related complaints were reported by CRC survivors who
were dissatisfied with participation than those who were satisfied
(sensory: 37.0 vs. 17.1, motor: 36.1 vs. 14.3, and autonomy: 34.4 vs.
9.7, respectively; Table 2).
Results of confounder-adjusted multivariable logistic regression
analyses are shown in Table 3. CRC survivors with better physical or
emotional role functioning were significantly less likely to be dis-
satisfied with their current participation 0.6, 95% CI: 0.5, 0.8; and OR
0.7, 95% CI: 0.5, 0.8, respectively). Additionally, survivors with a
higher level of fatigue were more likely to be dissatisfied with partici-
pation (OR 1.6, 95% CI: 1.2, 2.0). Associations for physical and emo-
tional role functioning and fatigue were not significant after adjustment
for each other (Table 3). CRC survivors who had received che-
motherapy, reported more CIPN symptoms, which was significantly
associated with an increased likelihood of dissatisfaction with partici-
pation (OR for sensory symptom: 0.6, 95% CI: 0.5, 0.9; for motor
symptoms: 0.6, 95% CI: 0.5, 0.9; and OR for autonomic symptoms: 0.6,
95% CI: 0.4, 0.8; Table 3).
3.2. Qualitative data
For the qualitative interviews, a total of 48 participants of the cross-
sectional EnCoRe study were eligible since they had previously reported
participation restrictions (Fig. 3). Based on data saturation we included
10 study participants in the qualitative part of the study. All ap-
proached interview candidates were willing to participate in the in-
terviews. As shown in Table 4, this purposive sample showed a ba-
lanced representation of the predefined relevant characteristics.
Interviews lasted for on average 1 h.
3.2.1. Participation restrictions mapped in the ICF conceptual model
As shown in Fig. 2, participation restrictions related to the CRC
diagnosis and treatment were mainly reported during the interviews
within the ICF domains of ‘D6 Domestic life’ regarding participation in
household tasks; ‘D7 Interpersonal relationships’ regarding formal, in-
formal, family, and interpersonal relationships; ‘D8 major life areas’
with respect to several aspects of work/employment, e.g. maintaining
and terminating a job, working hours (full-time/part-time work); and
‘D9 Community, social and civic life’ with respect to community life,
and recreation and leisure (sports, hobbies, arts and culture, crafts).
Additionally, the interview information about activity limitations,
impairments in body functions and structures related to the CRC and
treatment, as well as barriers and facilitators of environmental and
personal factors influencing health and functioning were also mapped
in the ICF framework (Fig. 2), showing other relevant factors men-
tioned by the participants which potentially influenced participation
restrictions. It is not surprising that all domains of the ICF are re-
presented because of the interview topics selected based on the ICF
framework, but it is of note that most of the interviewed survivors
mentioned problems in all domains.
3.2.2. Nature of participation restrictions and impact on daily life
Although treatment for CRC had occurred on average almost 7 years
ago, interview participants reported about the consequences of the
cancer (treatment) they still experienced in their daily lives. Several
CRC survivors reported restrictions in participation due to neuropathy
as result of the chemotherapy received, changing their lives. CRC sur-
vivors said they still had tingling or numb hands and/or feet, resulting
in the inability to execute hobbies they used to do before the CRC
(treatment), like model making, taking films or photographs, building
with building blocks, playing with grandson, repair of watches, and
recreational walking, swimming, recreational cycling, and gardening.
Like one of the interviewees explained:
‘I cannot go anywhere. I am only able to walk up and down the
street to take the dog out. I cannot even walk to the mailbox, be-
cause of my sore soles. This is worthless.’
Fatigue due to CRC treatment was reported to frequently affect
participation as well. Low energy levels were reported. Household tasks
were said to be more straining as compared to before CRC treatment.
Interviewed survivors indicated a limited ability to execute recreational
walking or cycling and an increased time to recover. One person in-
dicated:
‘The most difficult thing was that I was no longer able to go cycling
with my wife and her sister like before.’
Fatigue impacted interviewed CRC survivors, restricting them in the
ability for going out, in the ability to join friends when going e.g. into
town or visiting a museum, and limiting possibilities to make ap-
pointments and to be with friends due to lack of energy, resulting in a
narrow circle of acquaintances. Furthermore, CRC survivors reported
lacking stamina to participate in sports, and on the other hand also
reported to perform sports to regain health and physical fitness. Fatigue
made the participation in sports difficult, as one survivor experienced
difficulties in performing all necessary procedures, and another
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survivor decided to sport at home, as going out for sporting was too
energy-consuming. For some CRC survivors who used to work/do odd
jobs, treatment-induced fatigue and lack of muscle strength resulted in
the inability to carry on with work activities, or the necessity to reduce
working pace and -hours, and introducing frequent breaks (naps) to be
able to continue work. As one person reported:
‘After I was diagnosed with CRC, it took me one and a half years
before I was able to work again. Fatigue was a major problem, and I
still have to adapt my work pace and take several breaks during the
day, by taking a rest or by taking a nap, to enable myself to continue
my work’.
Fatigue restricted another participant in going on holidays.
Survivors mentioned the necessity to consider fatigue as part of the
daily life, and to spread energy-consuming tasks and events, as energy
was limited.
Treatment-induced bowel complaints impacted participation as
well. A change in defecation pattern, reaction of the bowel to specific
foods, and incontinence were reported. One participant reported only
leaving home after defecation (due to problems with continence), as he
was afraid to soil himself, and another one made sure to restrict food
and avoided specific foods which may cause problems on the day pre-
ceding the day the participant planned to go out to control defecation.
For another participant, daily bowel lavage helped to control defecation
again, and enabled him to work and travel again. In the next citation,
he explains how he tried to keep his defecation under control:
‘I have to limit some foods which may cause bowel complaints, like
onions and red peppers. I also need to take care of the amounts of
food I take. When I eat too much I may get bowel complaints and
incontinence.’
One participant who had a stoma reported that the stoma bag re-
stricted the ability for him to work in the garden. Another participant
adapted the portion size when eating cabbage to restrict flatulence.
Lastly, several interviewees reported difficulties to return to work or
the inability to work after and due to the CRC (treatment). Participation
problems resulting from premature return to work (3 months after
treatment) were reported by one survivor. Another person reported
being fired after the CRC and regretted the fact that he was forced to
stop with his work. One woman explained what losing her job meant to
Table 1
Socio-demographic and clinical characteristics of colorectal cancer survivors by satisfaction with societal participation yes or No (n = 151).
Total Sample Satisfaction with Societal Participationa
Yes No
Satisfaction with societal participation
Overall satisfaction with participation, n (%) 151 (100.0) 122 (80.8) 29 (19.2)
Satisfaction with paid Job 26 (17.2) 23 (88.5) 3 (11.5)
Satisfaction with unpaid job 35 (23.2) 33 (94.3) 2 (5.7)
Satisfaction with household tasks 125 (82,8) 110 (88.0) 15 (12.0)
Satisfaction with hobbies 151 (100.0) 135 (89.4) 16 (10.6)
Socio-demographic and clinical variables
Age, years, mean (SD) 69.8 (8.7) 70.1 (8.7) 68.1 (8.7)
Gender, n (%)
Men 94 (62.3) 80 (65.6) 14 (48.3)
Woman 57 (37.7) 42 (34.4) 15 (51.7)
Years since diagnosis, mean (SD) 5.7 (1.8) 5.7 (1.9) 5.8 (1.6)
Number of comorbidities, n (%)
0, n (%) 37 (24.5) 34 (28.1) 3 (10.3)
1, n (%) 37 (24.5) 32 (26.4) 5 (17.2)
2 or more, n (%) 76 (50.3) 55 (45.5) 21 (72.4)
BMI (kg/m2), mean (SD) 27.7 (4.3) 27.7 (4.1) 27.9 (5.2)
Smoking status, n (%)
Current smoker 16 (10.6) 12 (9.8) 4 (13.8)
Non-current smoker 135 (89.4) 110 (90.2) 25 (86.2)
Meeting Dutch PA guidelines, n (%)
Yes 76 (50.3) 65 (53.3) 11 (37.9)
No 75 (49.7) 57 (46.7) 18 (62.1)
Dietary change after colorectal cancer, n (%)
Yes 54 (35.8) 42 (34.4) 12 (41.4)
No 97 (64.2) 80 (65.6) 17 (58.6)
Cancer stage, n (%)
Stage I 42 (29.4) 35 (30.7) 7 (24.1)
Stage II 52 (36.4) 42 (36.8) 10 (34.5)
Stage III 49 (34.3) 37 (32.5) 12 (41.4)
Location of tumor, n (%)
Colon 80 (53.0) 66 (54.1) 14 (48.3)
Rectum and recto-sigmoid 71 (47.0) 56 (45.9) 15 (51.7)
Stoma, n (%)
Yes 26 (17.2) 17 (13.9) 9 (31.0)
No 125 (82.8) 105 (86.1) 20 (69.0)
Treatment with chemotherapy, n (%)
Yes 79 (52.3) 61 (50%) 18 (62.1)
No 72 (47.7) 61 (50%) 11 (37.9)
Living alone, n (%)
Yes 30 (19.9) 19 (15.6) 11 (37.9)
No 121 (80.1) 103 (84.4) 18 (62.1)
Abbreviations: BMI, body mass index; CRC, colorectal cancer; n, number; PA, Physical Activity; SD, standard deviation.
a Study participants were asked to report whether their current satisfaction with societal participation in paid job (yes/no), non-paid job (yes/no), household tasks
(yes/no), and hobbies (yes/no) was the same as compared to before their CRC diagnosis. A negative answer to at least one of the questions was considered to reflect
dissatisfaction with participation.
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her:
‘I was so happy with my new job. When I became ill, I received
chemotherapy, and I developed a fracture of the arm, which did not
heal well. The treatment also made me feel very tired. Therefore, I
was not able to return to my work and this felt like a punishment to
me. I miss my work and I miss the social contacts related to my
work. I used to undertake many activities with my colleagues, but I
lack the energy to be socially active.’
4. Discussion
In this mixed-method study, we analyzed whether role functioning,
fatigue, and CIPN symptoms were associated with CRC survivors’ sa-
tisfaction with participation. Nearly one in five long-term CRC survi-
vors reported to be dissatisfied with their current level of participation
2–10 years post-diagnosis. Qualitative analyses of interviews suggested
that several aspects of participation were restricted as a result of the
prior CRC diagnosis and treatment. Additionally, CRC survivors re-
porting better role functioning were significantly less likely to be dis-
satisfied with their current level of participation, whereas survivors
reporting higher levels of fatigue and more CIPN symptoms were more
likely to be dissatisfied with participation. Additionally, we qualita-
tively explored the nature and impact of persisting health and func-
tioning problems on participation of CRC survivors in everyday life
situations.
Dissatisfaction with participation was reported by 19% of the CRC
survivors, who considered their current ability to engage in jobs, do-
mestic life and/or hobbies unsatisfactory. This shows that a majority of
CRC survivors does not report dissatisfaction with these aspects of
participation, and this is in line with a study of Domati, indicating that
the majority of CRC survivors returned to normal life after 5 years
(Domati et al., 2011). In our study persisting problems related to CIPN,
fatigue, and bowel complaints resulting from the CRC diagnosis and
treatment were reported to be related to the restricted participation.
Thereby, these problems could have a huge impact on everyday life,
limiting the ability to participate in working activities and other
meaningful social activities. Results of a previous study using focus
groups to explore concerns of (short-term) CRC survivors, showed that
survivors were facing many challenges to adjust their lives and daily
activities after diagnosis and treatment (Ho MY et al., 2015). The study
of Desnoo et al. reports about difficulties in controlling and managing
symptoms of rectal cancer, and another study among rectal cancer
patients showed that work loss was significantly increased among stage
III patients who had received neo-adjuvant radiotherapy or chemo-ra-
diation (Chen et al., 2016; Desnoo and Faithfull, 2006). A review of
Drury gives an overview of a range of issues in CRC survivorship,
showing that CRC is a life-changing experience, with both positive and
negative outcomes affecting physical, psychological and social well-
being (Drury et al., 2017). Our findings are in line with these previous
findings and provide additional insight into the impact of CRC- and
treatment-related complaints on participation among those long-term
CRC survivors who reported dissatisfaction with participation, raising
awareness of the specific problems that these individuals face in their
daily lives. In our study adjustments in activities of everyday life, due to
effect of CRC (treatment) such as CIPN, fatigue, and bowel disfunction,
were reported as well, affecting the ability to function and participate at
home in household activities, and hobbies, and outside the house in
work, in social contact and in social activities.
Data are emerging on relationships of socio-demographic char-
acteristics, clinical factors, personality, and lifestyle factors with health-
related outcomes in CRC survivors, such as health-related quality of life,
fatigue, CIPN and physical and role functioning (Bours et al., 2016;
Breedveld-Peters et al., 2018; Husson et al., 2015a,b; Packel et al.,
2015; Rodriguez et al., 2015). Associations of elevated levels of fatigue
persisting after the end of treatment with impaired functioning and
Table 2
Descriptive statistics of the main determinants role functioning, fatigue and chemotherapy-induced peripheral neuropathy (CIPN) in the total sample of colorectal
cancer survivors and in strata based on reported satisfaction with societal participation (yes/no).
Main Determinants Total Sample Satisfaction With Societal Participation
Yes No
Physical role functioning,
RAND-36 subscale (scale: 0–100)a











RAND-36 subscale (scale: 0–100)a
























EORTC QLQ-CIPN20 subscale (scale: 0–100)d











EORTC QLQ-CIPN20 subscale (scale: 0–100)d











EORTC QLQ-CIPN20 subscale (scale: 0–100)d










Neuropathy, no chemotherapy treatmente
Sensory neuropathy
EORTC QLQ-CIPN20 subscale (scale: 0–100)d











EORTC QLQ-CIPN20 subscale (scale: 0–100)d











EORTC QLQ-CIPN20 subscale (scale: 0–100)d










Abbreviations: n, number; CIS, Checklist Individual Strength; CRC, colorectal cancer; EORTC QLQ-CIPN20, European Organization for the Research and Treatment of
Cancer chemotherapy-induced peripheral neuropathy 20 item questionnaire; RAND-36, 36 item Health Survey questionnaire; SD, standard deviation.
a Higher score indicating a better physical and emotional role functioning, respectively.
b Higher score indicating a more complaints of fatigue.
c Results of study participants who received chemotherapy as part of their treatment for colorectal cancer.
d Higher score indicating a more symptoms of neuropathy.
e Results of study participants who did not receive chemotherapy as treatment for their colorectal cancer.
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well-being have previously been reported (Husson et al., 2015a,b;
Russell et al., 2015; Wang et al., 2014). Additionally, a recent review in
a mixed cancer population (Mols et al., 2014a,b) reported that more
CIPN symptoms are likely to be negatively associated with health-re-
lated quality of life outcomes. Other studies reported that CRC survivors
suffering from CIPN complaints had deteriorated levels of physical ac-
tivity and limited ability to perform activities of daily living (Packel
et al., 2015; Padman et al., 2015; Tofthagen et al., 2013). Furthermore,
the level of functioning has been reported to be inversely associated
with the prior cancer diagnosis and treatment, showing a stronger de-
cline in age-related health conditions and functioning in cancer survi-
vors, including CRC survivors, as compared to age-matched controls
(Leach et al., 2016). Lower role functioning was also shown in CRC
survivors near the end of treatment (Russell et al., 2015). Lower phy-
sical, role- and physical functioning and global health status has been
reported specifically for CRC survivors with ostomy (Mols ref). We now
also found that common health and functioning problems experienced
by many CRC survivors post-treatment, including low levels of role
functioning and high levels of fatigue and more CIPN symptoms, were
significantly associated with a lower satisfaction perceived by CRC
survivors regarding their current level of participation. In this study we
also found that main reported participation restrictions were linked to
the inability to execute household activities, hobbies and sports due to
CIPN. Participations restrictions in our study were also linked to the
limitations in executing social activities and maintaining contacts, re-
creational activities and to work due to persisting fatigue, as well as the
inability to go out due to bowel complaints (incontinence or stoma).
This gives important additional insight in how participation restrictions
affect daily live and functioning of CRC survivors, and may explain the
lower satisfaction with societal participation found.
Healthcare services need to offer long-term follow up care to CRC
survivors, to enable identification of health information and supportive
care needs of those CRC survivors who suffer from a diversity of long-
term health and functioning problems, that impact their ability to
participate in activities of daily living and as a member of society. Both
the quantitative and qualitative results suggest that there is a need to
offer targeted evidence-based interventions to address problems ade-
quately. Other studies emphasize the need to support individual CRC
survivors in managing their disease, and address their met and unmet
needs, to support their recovery as well (Drury et al., 2017; McCaughan
et al., 2012). This starts with awareness amongst health care profes-
sionals of existing problems in CRC survivors. Based on identified
physical and psychosocial problems a (multi modal) intervention pro-
gram could be offered comprising for example a physical activity pro-
gram to reduce fatigue, psychological support to cope with complaints,
or reduce stress, and dietary advice to handle bowel complaints.
A main strength of the present study was our mixed-method ap-
proach. Next to the quantitative data, the qualitative data from face-to-
face interviews provided additional insight into the nature and impact
of participation restrictions on everyday life as experienced by long-
term CRC survivors. However, for measurement of satisfaction with
participation, self-constructed items were used which may limit the
reliability/validity of these items and thereby generalizability of find-
ings. Also, satisfaction with participation in the quantitative analyses
only reflects satisfaction with participation in paid job, non-paid job,
household activities, and hobbies. Although the sample size was small
and there was a risk of recall bias due to the retrospective questioning
in the interviews, the factors identified in our explorative qualitative
Table 3
Adjusted odds Ratio's and 95% confidence intervals of dissatisfaction with so-
cietal participation for the main determinants physical and emotional role
functioning, fatigue and chemotherapy induced peripheral neuropathy (CIPN)















0.6 (0.5–0.8) 0.7 (0.5–1.1)
Emotional role
functioningb
0.7 (0.5–0.8) 0.9 (0.7–1.1)
Fatiguec 1.6 (1.2–2.0) 1.2 (0.9–1.6)
Neuropathyd
- Sensory 0.6 (0.5–0.8)
- Motor 0.6 (0.5–0.8)
- Autonomy 0.6 (0.5–0.8)
Neuropathyd (in chemotherapy-treated survivors only)
- Sensory 0.6 (0.5–0.9)
- Motor 0.6 (0.5–0.9)
- Autonomy 0.6 (0.4–0.8)
Abbreviations: CI, Confidence Interval; OR, Odds Ratio.
a Total score for dissatisfaction with societal participation including sa-
tisfaction with housework, hobbies, paid and non-paid job.
b Measured by the RAND 36-item Health Survey (RAND-36), with a higher
score indicating a better physical or emotional role functioning.
c Measured by the Checklist Individual Strength (CIS), with a higher score
indicating higher levels of fatigue.
d Measured by the European Organization for the Research and Treatment of
Cancer Chemotherapy-Induced Peripheral Neuropathy 20-item questionnaire
(EORTC QLQ-CIPN20), with a higher score indicating higher levels of specific
neuropathy symptoms (sensory, motor or autonomy).
e Adjusted for age (years), gender, number of comorbidities(0/1/≥2), and
chemotherapy treatment (yes/no).
f Additionally adjusted for the other determinants in the study: physical role
functioning, emotional role functioning, and fatigue.
Table 4
Overview of characteristics of a subsample of colorectal cancer survivors
from the EnCoRe study, who participated in the semi-structured inter-
views (n = 10).



























Abbreviations: EnCoRe study, Energy for life after ColoRectal Cancer
study.
a These characteristics were used for the selection of interview can-
didates. Selection was based on the presence or absence of specific
characteristics, in order to retrieve a mixed interview population in which
all characteristics were represented.
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Fig. 2. Summary of main reported participation restrictions (n = 10) depicted in the international classification of functioning, disability and health conceptual
model.
Abbreviations: ICF, International Classification of Functioning, Disability and Health.
The colored section of the model represents the main reported participation restrictions related to the (treatment for) colorectal cancer of interview participants
(n = 10). Relevant factors from the other ICF domains: impaired body functions and structures and activity limitations, and contextual factors, being the en-
vironmental and personal factors influencing health and functioning, are presented as well.
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study may inform future (prospective) studies in this area. A limitation
of our study was its cross-sectional design. Consequently, the direc-
tionality of observed associations between health and functioning
problems and CRC survivors’ perceived satisfaction with participation
should be interpreted with caution. A further limitation might have
been that the response rate in the study was relatively low, and that our
study population consisted mostly of relatively healthy CRC survivors
2–10 years post-diagnosis. Furthermore, despite the fact that we
Fig. 3. Flow diagram of inclusion of individuals into the qualitative and quantitative parts of the present study.
aReasons for non-eligibility are given in order of exclusion; totals do not add up because some exclusion criteria applied concurrently.
bTotals do not add up because some individuals reported multiple reasons for non-participation.
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systematically linked interview questions on complaints related to the
CRC diagnosis and its treatment, a limitation of this study may also be
that we cannot rule out that interview participants have linked com-
plaints for other medical conditions (comorbidities) to the CRC (treat-
ment).
5. Conclusions
This study suggests that persisting health and functioning problems
related to the prior CRC diagnosis and treatment in long-term CRC
survivors can considerably restrict their participation in everyday life
situations, as well as their feeling of satisfaction with their current level
of participation. This study contributes to a better understanding of
cancer- and treatment-related problems that long-term CRC survivors
can face on a daily basis in their everyday life. This implies that CRC
survivors need to be supported to enable them to manage their after-
effects of CRC. In the follow up care for CRC survivors, health profes-
sionals need to identify health information and supportive care needs of
CRC survivors. Detections of problems CRC-survivors experience, and
that affect their functioning and participation, can be integrated in
routine follow up care visits. Extension of the period of follow up care
may be needed for that. Furthermore, problems need to be adequately
addresses with evidence based interventions in the area of physical
health, psychological health, and social health. In this way survivors
who suffer from long-term cancer- and treatment related problems af-
fecting their functioning and participation, are supported to improve
management of complaints. Future studies are needed to provide more
insight of how to improve participation of CRC survivors.
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